Trials / Withdrawn
WithdrawnNCT04384809
Platelet Rich Plasma Injection vs Percutaneous Tenotomy for Common Extensor Tendinopathy
Comparison of Leukocyte-rich Platelet Rich Plasma Injection to Percutaneous Tenotomy in the Treatment of Chronic Common Extensor Tendinopathy
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospitals Cleveland Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized control trial comparing the use of leukocyte rich platelet rich plasma injections to percutaneous tenotomy for the treatment of chronic common extensor tendinopathy.
Detailed description
This is a randomized control trial comparing the use of leukocyte rich platelet rich plasma injections to percutaneous tenotomy for the treatment of chronic common extensor tendinopathy. Patients with a history of common extensor tendinopathy for greater than 3 months, refractory to conservative treatments, are randomized into one of two groups: injection with leukocyte rich platelet rich plasma or percutaneous tenotomy with the Tenex system. Both groups of patients are followed up in clinic at 1 week, 2 weeks, 6 weeks, 3 months, 6 months, and 1 year following the procedure to examine levels of pain or complications following both procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Leukocyte rich platelet rich plasma | Leukocyte rich platelet rich plasma will be obtained and prepared from a peripheral artery of the subject and then will be injected in the common extensor tendon |
| DEVICE | Percutaneous Tenotomy | Patients will undergo percutaneous tenotomy of the common extensor tendon using the Tenex tenotomy device |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-05-01
- Completion
- 2023-05-01
- First posted
- 2020-05-12
- Last updated
- 2022-11-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04384809. Inclusion in this directory is not an endorsement.